Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

JFL Life Sciences Ltd

JFLLIFE.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.14

▲ +1.93%

Market Cap $9.13M · Vol 12.00K

Key Metrics

P/E Ratio

6.75

FWD: N/A

Market Cap

$9.13M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

68.22

Momentum

Beta

0.97

vs Market

52W High

$0.15

15.52% below

52W Low

$0.09

52.63% above

Volume

12.00K

Avg 46.20K

P/B

0.64

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, JFL Life Sciences Ltd (JFLLIFE.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does JFLLIFE.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.30%

+24.53%

+43.48%

+15.24%

YTD

+10.63%

+2.06%

-29.04%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$14.06M
Net Income	$684.91K
Revenue Growth (YoY)	N/A
Gross Margin	11.67%
Operating Margin	8.10%
Net Profit Margin	4.87%
ROE	N/A
ROA · ROIC	9.65% · 13.37%

P/E Ratio	6.75
Forward P/E (FY1)	N/A
PEG Ratio	0.07
P/S	0.21
P/B	0.64
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	65.99M

Technical Indicators

50-Day SMA	$0.11
200-Day SMA	$0.11
RSI (14)	68.22
Beta	0.97
52-Week High	$0.15
52-Week Low	$0.09

Volume Today	12.00K
Avg Daily Volume (30D)	46.20K
Relative Volume	0.26x
Volatility (10D)	49.66
Volatility (30D)	51.85
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.14

Mean Target N/A

52W Low$0.09 52W High$0.15

Current

Target

$0.09 $0.15

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG019BXDTQ8

ISININE0LA901015

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company's business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Company's main product categories include Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet, and capsules (General) and Oral Rehydration Solutions (ORS). Its beta-lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection, Cefazoline Sodium Injection, meropenem injection, amoxicillin injection, cefTAZidime injection, flucloxacillin injection, among others. Its beta-lactam tablets and capsule products include Cefadroxil Tablets, Cefadroxil Capsules, among others. Its general tablet and capsule products include Azithromycin Tablets, Iburofen Tablets, Ciprofloxacin Tablets, Ofloxacin Tablets, Paracetamol Tablets, among others. These products are offered in different milligrams (mg).